Show simple item record

dc.contributor.authorMoore, Brioni
dc.contributor.authorDavis, T.
dc.date.accessioned2018-12-13T09:13:40Z
dc.date.available2018-12-13T09:13:40Z
dc.date.created2018-12-12T02:47:10Z
dc.date.issued2018
dc.identifier.citationMoore, B. and Davis, T. 2018. Pharmacotherapy for the prevention of malaria in pregnant women: currently available drugs and challenges. Expert Opinion on Pharmacotherapy. 19 (16): pp. 1779-1796.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/72541
dc.identifier.doi10.1080/14656566.2018.1526923
dc.description.abstract

© 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group. Introduction: Malaria in pregnancy continues to be a significant public health burden globally, with over 100 million women at risk each year. Sulfadoxine-pyrimethamine (SP) is the only antimalarial recommended for intermittent preventive therapy in pregnancy (IPTp) but increasing parasite resistance threatens its viability. There are few other available antimalarial therapies that currently have sufficient evidence of tolerability, safety, and efficacy to replace SP. Areas covered: Novel antimalarial combinations are under investigation for potential use as chemoprophylaxis and in IPTp regimens. The present review summarizes currently available therapies, emerging candidate combination therapies, and the potential challenges to integrating these into mainstream policy. Expert opinion: Alternative drugs or combination therapies to SP for IPTp are desperately required. Dihydroartemisinin-piperaquine and azithromycin-based combinations are showing great promise as potential candidates for IPTp but pharmacokinetic data suggest that dose modification may be required to ensure adequate prophylactic efficacy. If a suitable candidate regimen is not identified in the near future, the success of chemopreventive strategies such as IPTp may be in jeopardy.

dc.titlePharmacotherapy for the prevention of malaria in pregnant women: currently available drugs and challenges
dc.typeJournal Article
dcterms.source.volume19
dcterms.source.number16
dcterms.source.startPage1779
dcterms.source.endPage1796
dcterms.source.issn1465-6566
dcterms.source.titleExpert Opinion on Pharmacotherapy
curtin.departmentSchool of Pharmacy and Biomedical Sciences
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record